30,000+ epitopes mapped with over 1,000 trusted partners in biotech, pharma, and academia
How our ADA epitope mapping works
Why choose PEPperPRINT for ADA Epitope Mapping?
We understand that getting early and accurate immunogenicity data is crucial for minimizing risks associated with immune adverse effects in biotherapeutic development. Our straightforward epitope mapping approach combines the power of the PEPperCHIP® Peptide Microarray platform with over a decade of scientific expertise:
Screen any protein
Analyze linear and conformational epitopes
High-resolution data
Identify epitopes at the amino-acid level
High-throughput analysis
Screen multiple targets, isotypes, or samples at once
Proven track record
ISO certified with over 300 customer publications
See it in action: ADA epitope mapping case study
PEPperPRINT's peptide microarrays have been successfully used to analyze ADA responses in different contexts. Read the case study to learn how our technology was used to:
- Compare ADA immunogenicity of two PD-L1 inhibitors, highlighting differences in patient responses
- Identify specific immunogenic sites linked to adverse effects in an anti-VEGF antibody
- Detect pre-existing antibody responses to CRISR/Cas proteins
Built for Everyone
Easy-to-use ensures new users learn to use prototyping tools.
